Zorn Rebecca E

EVP Rebecca Zorn sold 8,800 shares at avg $136.61; post-sale holding 17,797 shares (-33.1%)

Zorn executed 3 separate sales totaling 8,800 shares for $1,202,189.32 on 2026-03-31, reducing her position by 33.1% from 26,597 to 17,797 shares. The blended average transaction price of $136.61 compares favorably to the current price of $139.17 (the stock has risen 1.9% since the transaction). At Globe Life Inc.'s P/E of 8.82 with positive fundamentals (P/E ratio below market and annual revenue growth of 3.7%), this substantial reduction in an executive's stake warrants observation, though the magnitude—while significant in percentage terms—still leaves substantial residual holdings. Her prior sales at this ticker show mixed timing outcomes: 2 of 5 prior transactions were well-timed at the 90-day mark, suggesting no consistent pattern of anticipating near-term declines.

EVP Zorn sells 15,000 GL shares (52.4% of holdings) in 4 transactions for $2.0M at $135.58 avg

Rebecca E Zorn, EVP & Chief Talent Officer, executed 4 separate sales totaling 15,000 shares for $2,033,680.95 on 2025-07-25, reducing her holdings from 28,649 to 13,649 shares. The transaction prices ($134.55–$137.37) occurred near the 52-week high of $135.13, with the stock currently at $134.16 (-0.7% from that high). Her prior GL sales in May 2025 showed mixed near-term performance (-0.9%, -1.6%, -2.3% at 30 days), though her cross-ticker track record shows 0.00% well-timed sales rate at the 90-day horizon (average 90d return +5.2%), indicating her prior open-market exits have not consistently preceded declines. The company trades at a P/E of 10.34 with recent quarterly revenue of $1.5B and net income of $254.6M, suggesting a modestly valued financial services operator.

EVP Rebecca Zorn sold 10,000 shares (42.3% of pre-transaction holdings) for $1,210,856.89 at GL

Rebecca Zorn, EVP & Chief Talent Officer at Globe Life Inc., executed 3 separate sales totaling 10,000 shares for $1,210,856.89 on 2025-05-12, reducing her holdings from 23,649 shares to 13,649 shares. The sales occurred at prices of $120.84, $121.71, and $122.55 per share, within the 52-week range of $77.89–$133.09 and near the current price of $120.09. While the magnitude of the sale (-42.3% of her pre-transaction position) is material, her prior sell at this same ticker on 2023-11-30 posted a 90-day return of +5.2%, indicating the stock rallied after that previous sale rather than declined. The company's fundamentals remain solid with $1.5B in quarterly revenue, $254.6M net income, and a P/E of 9.25, offering no obvious distress signal.